Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.

The dispositions of cefotaxime and its metabolite desacetylcefotaxime were investigated in patients with different forms of chronic parenchymal liver disease (CPLD). A total of 31 subjects (27 patients and 4 controls) received a single 2-g dose of cefotaxime by infusion, and serial blood samples wer...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Ko, R J, Sattler, F R, Nichols, S, Akriviadis, E, Runyon, B, Appleman, M, Cohen, J L, Koda, R T
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1991
主題:	Research Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245175/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1929296/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.7.1376
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!